When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GWPH - GW Pharma's Epidiolex successful in late-stage study in another rare type of epilepsy
GW Pharmaceuticals Plc
GW Pharmaceuticals (NASDAQ:GWPH) is up 4% after hours on its Q1 beat and on a successful Phase 3 clinical trial evaluating Epidiolex (cannabidiol) in patients with a rare and severe type of childhood epilepsy called tuberous sclerosis complex (TSC).
More news on: GW Pharmaceuticals plc, Healthcare stocks news, Stocks on the move,